Roivant Sciences Ltd. Quarterly Assets in USD from Q1 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Roivant Sciences Ltd. quarterly Assets history and growth rate from Q1 2021 to Q3 2024.
Roivant Sciences Ltd. Assets for the quarter ending September 30, 2024 was $6.21B, a 200% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$6.21B	+$4.14B	+200%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$6.5B	+$4.36B	+204%	Jun 30, 2024	10-Q	2024-08-09
Q1 2024	$7.22B	+$4.83B	+202%	Mar 31, 2024	10-Q	2024-11-12
Q4 2023	$7.31B	+$5.11B	+232%	Dec 31, 2023	10-Q	2024-02-13
Q3 2023	$2.07B	-$150M	-6.77%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$2.14B	-$464M	-17.8%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$2.39B	-$196M	-7.56%	Mar 31, 2023	10-K	2024-05-30
Q4 2022	$2.2B	-$596M	-21.3%	Dec 31, 2022	10-Q	2023-02-13
Q3 2022	$2.22B	-$887M	-28.6%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$2.6B	+$146M	+5.94%	Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$2.59B	-$4.56M	-0.18%	Mar 31, 2022	10-K	2023-06-28
Q4 2021	$2.8B			Dec 31, 2021	10-Q	2022-02-14
Q3 2021	$3.1B			Sep 30, 2021	10-Q	2021-11-15
Q2 2021	$2.45B			Jun 30, 2021	10-Q	2021-09-21
Q1 2021	$2.59B			Mar 31, 2021	10-K	2022-06-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.